Peters on Diabetes

• Semaglutide Reduces Cardio Risk in Obesity Without Diabetes   Anne Peters discusses recent data on semaglutide and cardiovascular outcomes in patients with preexisting cardiovascular disease and obesity, but with no history of diabetes.
  Medscape Diabetes & Endocrinology, December 05, 2023
• Approval of Tirzepatide for Treating Obesity 'Exciting'   Dr Anne Peters explains why she is excited about the FDA approval of tirzepatide for weight loss.
  Medscape Diabetes & Endocrinology, November 16, 2023
  1
• 'Moving Targets': Adjusting GLP-1 Agonists and Insulin   GLP-1 agonists are not only for weight loss but also for patients with diabetes. Anne Peters, MD, discusses the importance of monitoring dosing between insulin and GLP-1 agonists.
  Medscape Diabetes & Endocrinology, November 08, 2023
• Diagnosing Diabetes: Monogenic Diabetes and Other Rare Forms   In the last of a four part series, Anne Peters, MD, discusses rare forms of diabetes, including monogenic diabetes.
  Medscape Diabetes & Endocrinology, October 13, 2023
  1
• Diagnosing Diabetes: Not So Simple   In the first of a four-part series, Anne Peters, MD, explains why diagnosing diabetes isn't necessarily easy.
  Medscape Diabetes & Endocrinology, October 13, 2023
  7
• Diagnosing Diabetes: Many Variations in Type 2 Profile   As part of a four-part series on diagnosing diabetes, Anne Peters, MD, discusses the many variations in type 2 and treating patients with type 2 diabetes.
  Medscape Diabetes & Endocrinology, October 13, 2023
  1
• Diagnosing Diabetes: 'Much to Consider' with Type 1   In part of a four-part series on diagnosing diabetes, Anne Peters, MD, explains what to consider in diagnosing type 1 diabetes in adults.
  Medscape Diabetes & Endocrinology, October 13, 2023
• Do New Weight Loss Meds Mean the End of Bariatric Surgery?   The volume of bariatric surgeries may be down, but that doesn't render this treatment option any less crucial, surgeon Miguel A. Burch, MD, tells Anne L. Peters, MD.
  Medscape Diabetes & Endocrinology, September 28, 2023
  8
• Semaglutide Offers 'Reprieve' in Adults With Type 1 Diabetes   Recent research found that prescribing semaglutide in adult patients with new-onset type 1 diabetes afforded a cessation of insulin use. However, Anne L. Peters, MD, says the reprieve is temporary.
  Medscape Diabetes & Endocrinology, September 13, 2023
  1
• Shifting Focus on Obesity: Don't Forget About Glucose   The recent American Diabetes Association meeting largely focused on obesity, leading Anne L. Peters, MD, to stress that glucose continues to matter.
  Medscape Diabetes & Endocrinology, July 14, 2023
  2
• Beta Cells From Stem Cells: Nearing a Cure for Type 1 Diabetes?   Anne L. Peters, MD, discusses clinical trial results of beta cells made from stem cells in patients with type 1 diabetes.
  Medscape Diabetes & Endocrinology, June 28, 2023
  5
• Automated Insulin Delivery System, Not an Artificial Pancreas   Anne L. Peters, MD, explains why the term artificial pancreas is wrong and why automated insulin delivery system is correct.
  Medscape Diabetes & Endocrinology, May 24, 2023
  5
• Increased CGM Access Can Improve Treatment of T2D   Medicare's recent decision to increase coverage of CGM for patients with type 2 diabetes who aren't on insulin is a "win-win," says Anne L. Peters, MD.
  Medscape Diabetes & Endocrinology, May 08, 2023
  1
• Why the Approval of MiniMed 780G Is a 'Quantum Leap' Forward   The FDA approval of the MiniMed 780G artificial pancreas promises better glucose control in patients with type 1 diabetes, and Dr Ann Peters is "excited" to use it with her patients.
  Medscape Diabetes & Endocrinology, April 26, 2023
  1
• Tidepool Loop Approval Gives More Choice in Managing T1D   The recent FDA approval of the Tidepool Loop app offers patients with type 1 diabetes more choice in managing their disease. Anne L. Peters, MD, explains why.
  Medscape Diabetes & Endocrinology, February 15, 2023
• 'Ozempic Face': Accepting Wrinkles for Improved Health   Some who are taking Ozempic are complaining about their faces thinning as an effect of this weight loss drug. Dr Anne Peters thinks the benefit of this new medication outweighs the risk.
  Medscape Diabetes & Endocrinology, February 03, 2023
  94
• 'Making Targets Easier to Achieve' Key in Diabetes Care   Anne L. Peters, MD, discusses how the new updates to the American Diabetes Association 2023 Standards of Care in Diabetes can help clinicians improve patient care.
  Medscape Diabetes & Endocrinology, December 22, 2022
  1
• Put the Patient First in Managing Hyperglycemia   The patient needs to come first in managing hyperglycemia, says Dr Anne Peters, who provides guidance on providing care particularly for patients in underresourced settings.
  Medscape Diabetes & Endocrinology, December 08, 2022
  3
• EASD 2022 New Studies Change Beliefs About Cardiovascular Disease   From timing of medications to supplement use, Dr Anne Peters reviews several recent studies that have changed beliefs in the realm of cardiovascular disease.
  Medscape Diabetes & Endocrinology, November 29, 2022
  16
• 'First Step' Toward Delaying Progression of Type 1 Diabetes   Dr Anne Peters discusses the approval of teplizumab and its potential impact in delaying the onset of stage 3 diabetes for patients age 8 years or older who currently have stage 2 type 1 diabetes.
  Medscape Diabetes & Endocrinology, November 22, 2022
  1
• Pemafibrate Didn't Improve CV Outcomes in Patients With T2D   Dr Anne Peters discusses the PROMINENT trial, which found that pemafibrate lowered triglycerides in patients with diabetes and hypertriglyceridemia but didn't improve cardiovascular outcomes.
  Medscape Diabetes & Endocrinology, November 21, 2022
  1
• EASD 2022 'Patients Need a Champion' for Their Diabetes Care   How do you advocate for your patients? How do you make sure their care is equitable? Anne L. Peters, MD, discusses the importance of advocacy.
  Medscape Diabetes & Endocrinology, October 03, 2022
• FreeStyle Libre 3: 'Almost Like Wearing Nothing'   Dr Anne Peters offers insight into her patients' reactions to the FreeStyle Libre 3 CGM, the smallest sensor available.
  Medscape Diabetes & Endocrinology, September 06, 2022
  16
• iLet System Simplifies Insulin Delivery for T1D   Dr Anne Peters offers perspective on how the iLet automated insulin system works and can improve management for patients with type 1 diabetes.
  Medscape Diabetes & Endocrinology, June 07, 2022
  1
• Tirzepatide: 'Exciting' and Promising in Lowering A1c   Tirzepatide is the newest player in the quest for lowering A1c in people with type 2 diabetes. Dr Anne Peters describes the novel agent -- what it can do for patients now and in the future.
  Medscape Diabetes & Endocrinology, May 23, 2022
  9
• Does COVID-19 Raise the Risk for Diabetes?   Is COVID-19 responsible for new-onset diabetes? Or are COVID infections bringing to light previously undiagnosed cases? Dr Anne Peters reviews recent studies around COVID and diabetes.
  Medscape Diabetes & Endocrinology, May 17, 2022
  4
• Therapies 'Not Used Enough' in Patients With T2D and CVD Risk   Dr Anne Peters discusses a paper demonstrating the low use of appropriate therapies in patients with type 2 diabetes and established cardiovascular risk.
  Medscape Diabetes & Endocrinology, May 04, 2022
  4
• What Is the Glycemic Risk Index and Why Do We Need It?   Dr Anne Peters discusses the development of the glycemic risk index, a new continuous glucose monitoring measure.
  Medscape Diabetes & Endocrinology, May 02, 2022
  2
• 'Worse Over Time': CDC Data on Diabetes and Obesity   "No surprise that we've gotten worse over time," Dr. Anne Peters discusses recent data from the CDC on diabetes and obesity in the United States.
  Medscape Diabetes & Endocrinology, March 02, 2022
  3
• Omnipod 5 Automated Insulin Delivery System Approval 'Exciting'   Dr Anne Peters discusses why she "can't wait to use" the newly approved Omnipod 5 Automated Insulin Delivery System in her patients.
  Medscape Diabetes & Endocrinology, February 16, 2022
  2
• Remission From Type 2 Diabetes Does Not Mean a Cure   Lifestyle changes including healthy diet and increased exercise can lead to remission for patients with type 2 diabetes, allowing them to stop medication. But it is not a cure, reports Dr Anne Peters.
  Medscape Diabetes & Endocrinology, January 11, 2022
  12
• A Cure for Type 1 Diabetes? Not Yet, but We're Getting Closer   Dr Anne Peters discusses results from recent studies suggesting that there may be a path to improving treatment for patients with type 1 diabetes.
  Medscape Diabetes & Endocrinology, December 30, 2021
  8
• Update: 2022 ADA Standards of Care   Dr Anne Peters discusses updates contained in the ADA 2022 Standards of Medical Care in Diabetes.
  Medscape Diabetes & Endocrinology, December 28, 2021
  4
• IDF 2021 100 Years of Insulin, but Millions Still Without Access   As we celebrate a century of insulin, we should not forget that many around the world can't afford this life-saving treatment.
  Medscape Diabetes & Endocrinology, December 02, 2021
  8
• EASD 2021 Final Roadmap on Type 1 Diabetes Management in Adults   Anne Peters, MD, discusses the consensus statement on managing type 1 diabetes in adults from the American Diabetes Association and the European Association for the Study of Diabetes.
  Medscape Diabetes & Endocrinology, November 15, 2021
• Metformin, Then What? More Findings From the GRADE Study   Dr Anne Peters discusses updated results from the GRADE study that were presented at the 2021 European Association for the Study of Diabetes (EASD) meeting.
  Medscape Diabetes & Endocrinology, November 03, 2021
  8
• CGM in Type 2 Diabetes: What I Learned From the MOBILE Study   Anne Peters discusses the benefit of CGM in patients with type 2 diabetes on basal insulin, adding that there is much to be done in educating both patients and healthcare professionals about CGM.
  Medscape Diabetes & Endocrinology, June 30, 2021
• ADA 2021 New Guidelines for Type 1 Diabetes in Adults: An Overview   Dr Anne Peters summarizes and gives highlights from the new ADA/EASD draft guidelines for the management of type 1 diabetes in adults.
  Medscape Diabetes & Endocrinology, June 28, 2021
  1
• All About Wegovy for Weight Loss   Anne Peters talks about the newly approved semaglutide (Wegovy) for weight loss -- the various trials, indications and warnings, dosing, and expectations.
  Medscape Diabetes & Endocrinology, June 21, 2021
  8
• Peters on Tirzepatide: 'Impressive, but We Need to Know More'   Dr Anne Peters discusses tirzepatide and the topline results from the SURPASS trials.
  Medscape Diabetes & Endocrinology, June 18, 2021
  1
• Updates on Semaglutide for Weight Loss, From ENDO 2021   Dr Anne Peters discusses updates from the STEP trials that were presented at ENDO 2021.
  Medscape Diabetes & Endocrinology, April 20, 2021
  3
• The Omnipod 5 System: Trial Results From ENDO 2021   Find out why Dr Anne Peters was 'incredibly excited' to see data presented from the Omnipod 5 clinical trials.
  Medscape Diabetes & Endocrinology, April 02, 2021
  1
• SGLT2 Inhibitors in T1D: 'People Are Using Them Now'   Dr Anne Peters talks about what you need to know regarding off-label use of SGLT2 inhibitors in type 1 diabetes.
  Medscape Diabetes & Endocrinology, March 30, 2021
• Managing Pregnancy in T1D: 'One of the Hardest Things We Do'   Dr Anne Peters discusses blood glucose targets and continuous glucose monitoring in pregnant patients with type 1 diabetes.
  Medscape Diabetes & Endocrinology, March 11, 2021
  2
• "Heart" of the New ADA Guidelines: Pharmacologic Approaches   Dr Anne Peters continues her overview of the ADA 2021 Standards of Care, focusing on the updates to pharmacologic management of glycemia.
  Medscape Diabetes & Endocrinology, January 07, 2021
• Key Changes to the 2021 ADA Standards of Care   Dr Anne Peters provides an overview of important changes to the first half of the ADA 2021 Standards of Care.
  Medscape Diabetes & Endocrinology, January 04, 2021
• ADA Guidelines: How Do They Come About?   Updating the ADA guidelines is a rigorous and formal process, with review of evidence and much consensus, says Dr Anne Peters.
  Medscape Diabetes & Endocrinology, December 28, 2020
  3
• A COVID-19 and Diabetes Update From Anne Peters   How are patients faring with the changes to diabetes care during the pandemic? Dr Anne Peters gives an update and highlights areas that need more focus.
  Medscape Diabetes & Endocrinology, December 04, 2020
  2
• EASD 2020 What Is LADA and How Should We Treat It?   A new consensus statement on LADA, or latent autoimmune diabetes in the adult, attempts to define this perplexing disease and give guidance on management.
  Medscape Diabetes & Endocrinology, October 23, 2020
  8
• EASD 2020 'Good News' From the FDA on Dulaglutide, Canagliflozin   Two label changes from the FDA mean good news for patients with diabetes, says Dr Anne Peters.
  Medscape Diabetes & Endocrinology, October 08, 2020
• EASD 2020 Insulin Updates From EASD 2020   Dr Anne Peters discusses recent data presented at the EASD meeting on ultra rapid-acting and once-weekly insulins.
  Medscape Diabetes & Endocrinology, October 05, 2020
• Off to College With T1D in the COVID Era: How to Prepare   For young people with type 1 diabetes facing college for the first time, there's much to consider, says Dr Anne Peters.
  Medscape Diabetes & Endocrinology, September 04, 2020
• Irl Hirsch Reviews ADA Highlights With Anne Peters   Drs Anne Peters and Irl Hirsch talk about newer insulins, the newly approved CGM device, and the highs and lows of attending a virtual conference.
  Medscape Diabetes & Endocrinology, July 01, 2020
  1
• Not Just About Blood Sugar: 'He Died Because He Lost His Job'   Dr Anne Peters discusses the effect of glycemic control on COVID outcomes and how economic pressures can further put patients with diabetes at risk.
  Medscape Diabetes & Endocrinology, May 15, 2020
  19
• Virtual Reality: Diabetes Care During COVID-19 and Beyond   Dr Anne Peters discusses the new normal of virtual reality and her personal experiences with telehealth.
  Medscape Diabetes & Endocrinology, April 23, 2020
  1
• COVID-19 and Diabetes: Patterns Emerge   Dr Anne Peters discusses the patients with diabetes who will need the most aggressive outpatient care when infected with COVID-19.
  Medscape Diabetes & Endocrinology, April 10, 2020
  16
• Diabetes and COVID-19: Three Patient Cases   How might COVID-19 affect patients with well-controlled type 1 or type 2 diabetes? Dr Anne Peters comments on three patient cases.
  Medscape Diabetes & Endocrinology, March 18, 2020
  4
• 'Everyone With Diabetes' Must Prepare for COVID-19   How will COVID-19 affect people with diabetes? Many unanswered questions remain, but there's much we can still do to prepare our patients, says Dr Anne Peters.
  Medscape Diabetes & Endocrinology, March 11, 2020
• 2020 ADA Standards: A 'New Concept' in Treating T2D   Dr Peters discusses the updates to the ADA Standards of Care on the pharmacologic treatment of type 2 diabetes.
  Medscape Diabetes & Endocrinology, February 28, 2020
  27
• New ADA Standards: Promoting Health   From alternative insulins to diabetes technology, Dr Anne Peters highlights some changes to the 2020 ADA Standards of Medical Care in Diabetes.
  Medscape Diabetes & Endocrinology, January 31, 2020
  2
• Emergency Preparedness With Diabetes: Two Rules   Dr Anne Peters has two plans for making sure life-saving insulin and other necessities for diabetes are at the ready in case of evacuation or emergency.
  Medscape Diabetes & Endocrinology, December 09, 2019
• Oral Semaglutide Brings GLP-1s to Primary Care   With similar benefits and risks as its injected counterpart, oral semaglutide's greatest benefit may be the ability to expand its use to primary care.
  Medscape Diabetes & Endocrinology, November 21, 2019
  2
• 'Better Glycemic Control Than I've Ever Seen'   Two fundamental changes in the management of type 1 diabetes has Dr Peters seeing excellent glycemic control in her patients.
  Medscape Diabetes & Endocrinology, October 25, 2019
  20
• Use Apps for Diabetes, but With Care   With the multitude of digital apps available for patients with diabetes, how do you know which ones are safe to use?
  Medscape Diabetes & Endocrinology, October 11, 2019
• Using Newer Diabetes Agents: Assess the Most Pressing Need   In patients with diabetes who have known CVD, heart failure, or CKD, the most pressing need is to start an agent that will lower their associated risks, says Anne Peters.
  Medscape Diabetes & Endocrinology, September 24, 2019
• Nasal Glucagon a 'Huge Advance' for Caregivers   Treating a loved one who is having an episode of severe hypoglycemia can be a frightening experience. Dr Anne Peters discusses the promising use of recently approved nasal glucagon.
  Medscape Diabetes & Endocrinology, September 16, 2019
• Reducing Kidney and CV Complications in Diabetes   Kidney and cardiovascular disease are linked epidemiologically. Prof Rossing reviews potential new therapies with Dr Peters but notes that there is room for improvement in basic practice.
  Medscape Diabetes & Endocrinology, July 26, 2019
  1
• ACC Empowers Cardiologists to Use Diabetes Drugs for Heart Disease   The ACC Expert Consensus Pathway puts cardiologists on track to use novel diabetes drugs to prevent heart failure in high-risk patients, says Dr Anne Peters.
  Medscape Diabetes & Endocrinology, July 24, 2019
  7
• Nutrition Therapy for Adults With Diabetes or Prediabetes   Dr Anne Peters discusses the new guidelines for nutrition therapy for adults with diabetes or prediabetes.
  Medscape Diabetes & Endocrinology, June 25, 2019
  5
• CREDENCE Shifts Our Thinking About SGLT2 Inhibitors   The CREDENCE trial allows us to start thinking of SGLT2 inhibitors as drugs for preserving renal function, independent of other parameters, says Anne Peters.
  Medscape Diabetes & Endocrinology, June 14, 2019
  3
• What's New in the 2019 Standards of Medical Care in Diabetes   From telemedicine to patient education and lifestyle management, Dr Peters highlights key changes to this year's ADA standards for diabetes care.
  Medscape Diabetes & Endocrinology, February 07, 2019
  9
• Teaching Patients How to Use Inhaled Insulin   Dr Anne Peters says that the key to getting patients to comfortably use inhaled insulin is in the teaching. Mark Harmel demonstrates how.
  Medscape Diabetes & Endocrinology, January 31, 2019
  5
• Putting the ADA/EASD Glycemic Management Algorithm to Use   The recent ADA/EASD guideline on managing hyperglycemia in T2D is complicated and may seem daunting. Dr Anne Peters simplifies and reviews the key frames of the guideline.
  Medscape Diabetes & Endocrinology, January 24, 2019
  8
• Making the Switch: When Your Patient Can't Afford Insulin   For many patients, analogue insulin is simply unaffordable, but using non-analogue insulin can get complicated. Dr Anne Peters shares her tips and tricks for making a safe transition.
  Medscape Diabetes & Endocrinology, January 17, 2019
  14
• Cardiovascular Outcomes Trials Give 'Comforting' Results   Dr Anne Peters gives us her take on the recent CARMELINA, DECLARE-TIMI, and REWIND trials and their cardiovascular outcomes.
  Medscape Diabetes & Endocrinology, December 13, 2018
  1
• 'Life Behind the 8-Ball': Kids With Type 2 Diabetes   Especially in underserved areas of Mississippi, children with type 2 diabetes face an uphill battle, and clinicians have to arm them appropriately for the fight.
  Medscape Diabetes & Endocrinology, August 02, 2018
  3
• 'Really Good' New Guidelines for T2 Diabetes   Dr Anne Peters applauds the latest changes to guidelines that put cardiovascular risk at the forefront of type 2 diabetes management.
  Medscape Diabetes & Endocrinology, July 16, 2018
  70
• New Diabetes Guidelines Already Outdated?   The ACP reviewed relevant studies but came to conclusions 'not germane to the way we treat patients with type 2 diabetes today,' says Dr Anne Peters.
  Medscape Diabetes & Endocrinology, April 12, 2018
  26
• Refer Medicare Patients for Free Diabetes Prevention Program   A new Medicare benefit can help patients prevent diabetes and improve other aspects of their health, says Dr Anne Peters.
  Medscape Diabetes & Endocrinology, March 22, 2018
  8
• New Diabetes Guidelines Fail to Guide   An effort to encourage individualized treatment choices may muddy the therapy waters, says Dr Peters.
  Medscape Diabetes & Endocrinology, January 19, 2018
  19
• 'Now Is the Time to Learn' About CGM   The FreeStyle Libre, a newly approved device for continuous glucose monitoring, is a big advance for people with diabetes who want to avoid finger sticks, says Dr Anne Peters.
  Medscape Diabetes & Endocrinology, November 10, 2017
  6
• Ultra-fast Insulins Curb Mealtime Spikes   Faster-acting insulins are especially beneficial for patients on continuous glucose monitors who are keeping track of glucose peaks and valleys.
  Medscape Diabetes & Endocrinology, October 27, 2017
  4
• Tips for Demystifying Injections in Diabetes   Dr Anne Peters demonstrates how she teaches injection techniques to patients with diabetes.
  Medscape Diabetes & Endocrinology, October 12, 2017
  9
• Helping Diabetes Patients Exercise Without Fear   Managing blood sugar during and after exercise can be challenging, but clinicians can help patients avoid highs and lows.
  Medscape Diabetes & Endocrinology, October 09, 2017
  1
• Two 'Incredibly Useful' Tools for Managing Diabetes   Dr Anne Peters demonstrates two continuous glucose monitors--one that provides blood glucose values in real time, and one that lets physicians see 2 weeks of values retrospectively.
  Medscape Diabetes & Endocrinology, September 07, 2017
  21
• Two New Combination Injectable Drugs for Type 2 Diabetes   These two new drug combinations will offer better glucose control and simplify the regimen for patients with inadequately controlled type 2 diabetes.
  Medscape Diabetes & Endocrinology, January 24, 2017
  10
• The First FDA-Approved Artificial Pancreas System   Dr Peters talks about the first hybrid closed-loop system to be approved by the FDA for the treatment of type 1 diabetes. What is it, how does it work, and what are its limitations?
  Medscape Diabetes & Endocrinology, January 11, 2017
• 'Incredibly Exciting': Diabetes Drug With CV Benefits   The FDA's recent addition of a cardiovascular indication for diabetes drug empagliflozin is a significant milestone in diabetes care, says Dr Anne Peters.
  Medscape Diabetes & Endocrinology, December 21, 2016
  22
• Prediabetic Feet Deliver Profound Message   The healthy feet of patients with prediabetes represent a special opportunity for medical providers, says Dr Anne Peters.
  Medscape Diabetes & Endocrinology, November 15, 2016
  57
• 'We Need to Move Forward': CGM in Diabetes   Sensors matched with insulin pumps beat finger sticks and multiple daily injections, says Dr Anne Peters, so we need 'real science' to determine the value of continuous glucose monitoring in diabetes.
  Medscape Diabetes & Endocrinology, November 07, 2016
  5
• Diabetes Drugs: The Latest Good -- and Bad -- News   Dr Anne Peters discusses hot topics in type 2 diabetes treatment: liraglutide shows CV benefits, whereas some SGLT2 inhibitors show renal protection -- and potential harm.
  Medscape Diabetes & Endocrinology, August 16, 2016
  21
• New Metformin Rule 'Makes Me Incredibly Happy'   New prescribing guidelines for metformin will make clinicians' lives easier, and they are good for patients, too, says Dr Anne Peters.
  Medscape Diabetes & Endocrinology, June 08, 2016
  61
• Wait for It: Diabetes News Eagerly Anticipated   Dr Anne Peters reveals which stories she will be following during the upcoming meeting of the American Diabetes Association in New Orleans.
  Medscape Diabetes & Endocrinology, June 03, 2016
  6
• Lower CV Risk -- With a Diabetes Drug   Dr Peters shares a recent case where she prescribed diabetes drugs for the purpose of helping a patient reduce his cardiovascular disease risk.
  Medscape Diabetes & Endocrinology, April 01, 2016
  48
• What I Want for Christmas (Next Year)   Dr Anne Peters shares her holiday "wish list" for improvements in diabetes care in the coming year.
  Medscape Diabetes & Endocrinology, December 23, 2015
  2
• New Insulins: Benefits and Challenges   Dr Anne Peters explains why new insulin products have clinical benefits and how their higher costs can be managed, especially at the end of the year.
  Medscape Diabetes & Endocrinology, December 11, 2015
  20
• How EMPA-REG Has Changed My Practice   The EMPA-REG Outcomes trial found that the diabetes drug empagliflozin was not only safe but it actually provided cardiovascular benefits in high-risk patients.
  Medscape Diabetes & Endocrinology, November 09, 2015
  8
• Minimizing DKA Risk With SGLT2 Inhibitors in Type 1 Diabetes   Could dose titration and ketone monitoring make drugs designed for type 2 diabetes safe in type 1 diabetes?
  Medscape Diabetes & Endocrinology, October 28, 2015
  16
• Type 2 Diabetes Management: Choosing the Best Therapies   Two experts offer tips for sifting through the many drug options to help patients optimize management of their type 2 diabetes.
  Medscape Diabetes & Endocrinology, October 09, 2015
  72
• Demystifying the Glycemic Index: Implications for Practice   What characteristics give a food its glycemic index? What are the benefits of a low-glycemic diet? A nutritionist explains why a low-glycemic-index diet is a shortcut to health.
  Medscape Diabetes & Endocrinology, June 30, 2015
  26